Evidence map›Paper›PMID 28287429›Full record

ArticleInternational journal of molecular sciences2017

d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study.

Defa Bai, Siming Yu, Shenghui Zhong, Bingxin Zhao, Shaoling Qiu, Jianwei Chen, Jignesh Lunagariya, Xiaojian Liao, Shihai Xu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. The role of cullin4B in human cancers.Experimental hematology & oncology · 2017
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Defa BaiCollege of Pharmacy, Jinan University, Guangzhou 510632, China. baidf@foxmail.com.
Siming YuKey Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou 510632, China. siming_yu@hotmail.com.
Shenghui ZhongDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China. zhongsh@stu2014.jnu.edu.cn.
Bingxin ZhaoDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China. zbx840622@163.com.
Shaoling QiuDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China. qslhappyrain@gmail.com.
Jianwei ChenDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China. 18826237580@163.com.
Jignesh LunagariyaDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China. jignesh.lunagariya@gmail.com.
Xiaojian LiaoDepartment of Chemistry, College of Chemistry and Materials Science, Jinan University, Guangzhou 510632, China. tliaoxj@jnu.edu.cn.
Shihai XuCollege of Pharmacy, Jinan University, Guangzhou 510632, China. txush@jnu.edu.cn.
Jinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galaxamide, an extract from

Indexed as

Amino AcidsAntineoplastic AgentsApoptosisHeLa CellsHep G2 CellsHumansMCF-7 CellsPeptides, CyclicAmino AcidsAntineoplastic AgentsgalaxamidePeptides, Cyclicanticancercyclopeptide">d-amino acidGalaxamide analogsmechanism

Identifiers

PMID28287429
PMCPMC5372560
OpenAlexW2593389124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.